SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed on March 8, 2021, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The registrant is a Delaware corporation incorporated in 2017, with principal executive offices in Carlsbad, California. The filing serves as a Regulation FD disclosure regarding an upcoming investor presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The document solely announces a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
Management announced participation in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. A slide presentation containing management commentary and potential outlook was attached as Exhibit 99.1. The filing explicitly states that the information in the presentation is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the company name is Ra Medical Systems, Inc. (RMED), not Catheter Precision, Inc.
- Review Exhibit 99.1 (Corporate Presentation dated March 8, 2021) for actual financial data and strategic outlook, as this 8-K only references the presentation.
- Note that the presentation materials are not legally "filed" with the SEC under Section 18 liability standards.
- Confirm the conference dates (March 9-10, 2021) to access any live management commentary.